Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NTP and ephedra

This article was originally published in The Tan Sheet

Executive Summary

National Toxicology Program's Board of Scientific Counselors will consider comments and data on toxicology of ephedrine alkaloid dietary supplements Sept. 18 in Research Triangle Park, N.C., according to an 1Aug. 19 Federal Register notice. In June, an NTP committee recommended that ephedrine alkaloid supplements undergo various toxicological studies and requested public feedback by Aug. 12 2("The Tan Sheet" July 1, 2002, p. 20). In comments, Bradenton, Fla.-based Med-Tox Group cautions NTP testing of ephedrine alkaloids "may be compromised by the true identity of the substance tested, and its relevance to commercial products." Separately, a U.S. Army Forces Command senior physician assistant notes ephedra products still are sold on military bases "in part due to a lack of 'scientific study' and proof that they are in fact hazardous when used in high physical stress and high temperature environments"...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS094457

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel